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Serum Magnesium: A Clinical Biomarker for 
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ABSTRACT
Introduction: Epilepsy is one of the most common chronic neurological disorder in the world and has a higher 
mortality rate than would be expected in a healthy population. One of the most related category of death 
is sudden unexpected death in epilepsy (SUDEP). Many risk factors have been related to SUDEP, but the 
mechanisms involved in its genesis is still unknown. Objective: Here we describe one case of a patient with 
low serum magnesium levels that suffered of SUDEP. Conclusion: we discuss a possible cause-effect relation, 
suggesting that magnesium may be, in some cases, a biomarker of SUDEP.
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RESUMO
Magnésio sérico: um biomarcador cerebral para morte súbita em epilepsia?
Introdução: Epilepsia é uma das doenças neurológicas crônicas mais comuns, com uma elevada taxa de 
mortalidade quando comparada com a população saudável. Uma das principais causas de morte é a morte 
súbita em epilepsia (SUDEP). Muitos fatores de risco têm sido correlacionados com SUDEP, mas os mecanismos 
envolvidos na sua gênese são ainda desconhecidos. Objetivos: será descrito um caso de um paciente com nível 
sérico de magnésio baixo que sofreu SUDEP. Conclusões: discutiremos uma possível relação de causa-efeito, 
sugerindo que o magnésio pode ser, em alguns casos, um biomarcador de SUDEP.
Unitermos: epilepsia, magnésio, morte súbita.
INTRODUCTION
Epilepsy is one of the most common chronic neurological 
disorder in the world and influences negatively the quality 
of people’s life affected by this disease. Approximately 3 
percent of the persons in the general population will have 
epilepsy at some point in their life.1 Unfortunately, mortality 
rates are considerably higher in people with epilepsy than 
would be expected in a healthy population. Thus, most 
of the excess is due to underlying disease, but some is 
epilepsy related, including trauma, suicide, pneumonia, 
status epilepticus, and sudden unexpected death in epilepsy 
(SUDEP), the most common epilepsy-related category 
of death.2,3 Currently, SUDEP is responsible for 7.5% to 
17% of all deaths in epilepsy and has an incidence among 
adults between 1:500 and 1:1,000 patient-years.4 Some 
characteristics are shared by patients at highest risk for 
SUDEP, such as refractoriness of the epileptic condition, 
presence of generalized tonic-clonic seizures, polytherapy 
with antiepileptic drugs, young age, duration of the seizure 
disorder, early onset of epilepsy and winter temperatures.5,6 
The mechanisms of death in SUDEP remain unknown, 
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however, there are several evidences supporting that one 
of the most important domain of potential mechanism of 
SUDEP is cardiovascular.7
Actually, many biomarkers have been shown to predict 
cardiovascular mortality in the general population8; 
however, this perspective is rarely assessed in research on 
SUDEP. Accordingly, as previous and very recent studies 
in the Atherosclerosis Risk in Communities (ARIC) cohort 
have shown that low levels of serum magnesium (Mg) are 
considered to be at high risk for sudden cardiac death9,10, 
the present study aims to demonstrate a typical case of 
SUDEP and highlights a possible biomarker that may 
have triggered a fatal cardiac event in this individual with 
epilepsy: low levels of serum magnesium (Mg).
CASE HISTORY
A 36-year-old male with normal neurodevelopment 
had two brief febrile seizures in the first year of life. At 11 
years old patient started with complex partial seizures that 
consisted of conscious loss followed by oral automatisms 
with occasional tonic-clonic secondary generalization. MRI 
revealed left mesial temporal sclerosis and EEG showed left 
anterior temporal lobe discharges. Patient evolved with 
seizure refractoriness despite use of antiepileptic drugs 
in monotherapy and politherapy. General biochemistry 
blood examination was normal, except for low levels of 
serum Mg: 0.64 mg/dl (normal range = 1.8 to 3.0 mg/dl). 
Unfortunately, one Saturday morning patient was found 
dead in bed after an uneventful day with his family. In 
general, patient was in a good state of health and post-
mortem examination did not reveal any abnormality. In 
the vernacular of the world of epilepsy, the patient suffered 
what is called SUDEP.
DISCUSSION
In this study we demonstrated a classic case of SUDEP 
probably associated with low levels of serum magnesium, 
which may be considered an interesting and promising 
biomarker for SUDEP. A number of arguments could be 
put forward to explain our proposal.
For over a decade there are significant evidence 
showing that Mg is able to suppress early ventricular 
arrhythmias and QT dispersion in patients with acute 
myocardial infarction.10,11 Furthermore, it has been know 
that Mg deficiency results in progressive vasoconstriction 
of the coronary vessels leading to a marked reduction in 
oxygen and nutrient delivery to the cardiac myocytes.12 
Additionally, several experimental and clinical studies 
have suggested that Mg abnormalities may lead to various 
morphological and functional abnormalities of the heart, 
since Mg deficiency is able to induce elevation of intracellular 
Ca2+ concentrations, formation of proinflammatory agents, 
oxygen radicals, growth factors and changes in membrane 
permeability and transport processes in cardiac cells.12 In 
parallel, there is a direct relationship between the decrease 
of Mg in myocardial tissue of individuals who died suddenly 
when compared with those dying of other causes.10,13
On the whole, although some studies have shown a 
relationship between serum Mg deficiency and refractory 
epilepsy in both children and adults,14,15 our analysis is the 
first to demonstrate a possible significant risk of SUDEP in 
individuals with low levels of serum Mg. In this sense, we 
have to keep in mind that as Mg is a potential modulator 
of seizure activity (because of its ability to antagonize 
the excitatory calcium influx through the N-methyl-
D-aspartate (NMDA) receptor),15,16 its serum levels 
reduction in people with refractory epilepsy can increase 
the frequency of seizures in these individuals, which is 
currently considered the most important risk factor for 
occurrence of SUDEP.3,6
Despite some progress, SUDEP remains a significant 
clinical problem. Unfortunately, all the risk factors, the 
mechanisms, specific methods to prevent, and specific 
biomarkers for SUDEP are yet to be obtained. Furthermore, 
we are sure that randomized, controlled trials will be 
required to investigate with precision the relation of low 
levels of serum Mg in individuals that suffered of SUDEP; 
however, as the walk always begins with the first step, this 
is a specific line of research in the SUDEP field that should 
be carefully investigated.
ACKNOWLEDGEMENT
The authors thank FAPESP, CInAPCe-FAPESP, INCT/
MCT and CNPq for supporting our studies.
REFERENCES
1. Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003;349: 
1257-66.
2. Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. 
Lancet 2006;367:1087-100.
3. Nashef L, Ryvlin P. Sudden unexpected death in epilepsy (SUDEP): 
update and reflections. Neurol Clin 2009;27:1063-74.
4. Schuele SU, Widdess-Walsh P, Bermeo A, Lüders HO. Sudden 
unexplained death in epilepsy: the role of the heart. Cleve Clin J 
Med 2007;74:S121-7.
5. Stollberger C, Finsterer J. Cardiorespiratory findings in sudden 
unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 
2004;59:51-60. 
6. Surges R, Thijs RD, Tan HL, Sander JW. Sudden unexpected death 
in epilepsy: risk factors and potential pathomechanisms. Nat Rev 
Neurol 2009;5:492-504. 
7. Surges R, Taggart P, Sander JW, Walker MC. Too long or too short? 
New insights into abnormal cardiac repolarization in people with 
chronic epilepsy and its potential role in sudden unexpected death. 
Epilepsia 2010;51:738-44.
8. Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC 
Med 2010;7;8:34.
77
Magnesium and sudden unexpected death in epilepsy
  9. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration 
a risk factor for coronary heart disease? The Atherosclerosis 
Risk in Communities (ARIC) Study. Am Heart J 1998;136: 
480-90.
10. Peacock JM, Ohira T, Post W, et al. Serum magnesium and risk of 
sudden cardiac death in the Atherosclerosis Risk in Communities 
(ARIC) Study. Am Heart J. 2010; 160:464-70.
11. Parikka H, Toivonen L, Naukkarinen V, et al. Decreases by magnesium 
of QT dispersion and ventricular arrhythmias in patients with acute 
myocardial infarction. Eur Heart J 1999;20:111-20.
12. Chakraborti S, Chakraborti T, Mandal M, et al. Protective role of 
magnesium in cardiovascular diseases: a review. Mol Cell Biochem 
2002;238:163-79.
13. Eisenberg MJ. Magnesium deficiency and sudden death. Am Heart J 
1992;124:544-9.
14. Benga I, Baltescu V, Tilinca R, et al. Plasma and cerebrospinal fluid 
concentrations of magnesium in epileptic children. J Neurol Sci 
1985;67:29-34.
15. Sinert R, Zehtabchi S, Desai S, et al. Serum ionized magnesium and 
calcium levels in adult patients with seizures. Scand J Clin Lab Invest 
2007;67:317-26.
16. Hallak M. Effect of parenteral magnesium sulfate administration 
on excitatory amino acid receptors in the rat brain. Magnes Res 
1998;11:117-31.
Corresponding author:
Fulvio A. Scorza
Rua Botucatu, 862 – Edifício Leal Prado
CEP 04023-900, São Paulo, SP, Brasil
Phone: (+55-11)- 5549-2064 – Fax: (+55-11) 5573-9304
E-mail: <address: scorza.nexp@epm.br>
